Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) - Initiation Phase

The percentage of children newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication who had at least three follow-up care visits within a 300-day (10 month) period, one of which was within 30 days of when the first ADHD medication was dispensed. 


• Initiation Phase. The percentage of members 6–12 years of age with a prescription dispensed for ADHD medication, who had one follow-up visit with a practitioner with prescribing authority during the 30-day initiation phase.

Measure Identifier: HEDIS_ADD-E.INI

Customize
View: Totals By Submitter      Trend type: Line Bar       Hide confidence intervals       Hide labels       Hide graphs       Hide tables
Print | PDF

Please see Report Details below for more information on selected subgroups, organizations, and aggregation.

Tables

Data


HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Report Details

Generated on Aug 31 2026 at 10:20
Measures: Follow-Up Care for Children Prescribed ADHD Medication (ADD-E) - Initiation Phase
Max Time Periods: 16
Organizations: All (aggregated)

Citation: NH Department of Health and Human Services. Bureau of Program Quality. Report generated on Aug 31 2026 at 10:20. [http://medicaidquality.nh.gov]

Disclaimer: While the NH Department of Health and Human Services - Bureau of Program Quality makes every effort to post accurate and reliable information, it does not guarantee or warrant that the information on this website is complete, accurate or up-to-date and assumes no responsibility for the use or application of any posted material.